US Stock MarketDetailed Quotes

Royalty Pharma (RPRX)

Watchlist
  • 39.530
  • -0.190-0.48%
Trading Jan 16 11:39 ET
16.89BMarket Cap22.59P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Royalty Pharma (RPRX) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/Q3
Stock NameRevenueRatio
Cystic fibrosis franchise214.25M35.16%
Other products164.15M26.94%
Evrysdi54.9M9.01%
Voranigo40.18M6.59%
Trelegy39.86M6.54%
Tremfya37.42M6.14%
Other royalty income and revenues30.48M5.00%
TYSABRI28.05M4.60%
View all

By Country/Region

Currency:USD
2024/FY
Stock NameRevenueRatio
United States2.26B100.00%
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.66%
Sample Name
Sample Code
 +2.90%
Sample Name
Sample Code
 +2.35%
4
Broadcom
AVGO
+1.39%
5
Microsoft
MSFT
+0.91%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.52%
Sample Name
Sample Code
 +10.35%
Sample Name
Sample Code
 +9.10%
4
Kingsoft Cloud
KC
+6.81%
5
Taiwan Semiconductor
TSM
+6.35%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -